Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Coronavirus Disease 2019 Policy Restricting Family Presence May Have Delayed End-of-Life Decisions for Critically Ill Patients

Producción científica: Articlerevisión exhaustiva

26 Citas (Scopus)

Resumen

OBJECTIVES: To determine if a restrictive visitor policy inadvertently lengthened the decision-making process for dying inpatients without coronavirus disease 2019. DESIGN: Regression discontinuity and time-to-event analysis. SETTING: Two large academic hospitals in a unified health system. PATIENTS OR SUBJECTS: Adult decedents who received greater than or equal to 1 day of ICU care during their terminal admission over a 12-month period. INTERVENTIONS: Implementation of a visit restriction policy. MEASUREMENTS AND MAIN RESULTS: We identified 940 adult decedents without coronavirus disease 2019 during the study period. For these patients, ICU length of stay was 0.8 days longer following policy implementation, although this effect was not statistically significant (95% CI, -2.3 to 3.8; p = 0.63). After excluding patients admitted before the policy but who died after implementation, we observed that ICU length of stay was 2.9 days longer post-policy (95% CI, 0.27-5.6; p = 0.03). A time-to-event analysis revealed that admission after policy implementation was associated with a significantly longer time to first do not resuscitate/do not intubate/comfort care order (adjusted hazard ratio, 2.2; 95% CI, 1.6-3.1; p < 0.0001). CONCLUSIONS: Policies restricting family presence may lead to longer ICU stays and delay decisions to limit treatment prior to death. Further policy evaluation and programs enabling access to family-centered care and palliative care during the ongoing coronavirus disease 2019 pandemic are imperative.

Idioma originalEnglish
Páginas (desde-hasta)E1037-E1039
PublicaciónCritical Care Medicine
Volumen49
N.º10
DOI
EstadoPublished - oct 1 2021

Nota bibliográfica

Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.

Financiación

Dr. Turnbull’s institution received funding from the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute; she received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)K01HL141637

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Critical Care and Intensive Care Medicine

    Huella

    Profundice en los temas de investigación de 'Coronavirus Disease 2019 Policy Restricting Family Presence May Have Delayed End-of-Life Decisions for Critically Ill Patients'. En conjunto forman una huella única.

    Citar esto